Shandong Weigao Group Medical Polymer Company Limited (01066) disclosed a repurchase of 60,000 H shares on 23 February 2026 at an average price of HKD 5.24. Prior to this transaction, the company had 4.48 billion shares in issue (excluding treasury shares) and approximately 41.52 million shares held as treasury shares. After the repurchase, the total number of issued shares remains at about 4.52 billion, while treasury shares have increased to about 41.58 million.

According to the announcement, the repurchase was conducted on the Hong Kong Stock Exchange, with the total consideration reaching HKD 314,200. This repurchase is part of the company’s ongoing buyback mandate approved on 27 May 2025, under which a maximum of 451.56 million shares can be repurchased.

The announcement also noted no indication of further share issues or sales of treasury shares within 30 days following the repurchase, aligning with Hong Kong listing rules.